Liver Cancer


Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer (02-20-2018)

CancerConnect News:  Treatment with Cabometyx  (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest that it could offer a new treatment option for this patient population. ... Continue Reading

Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer (02-15-2018)

CancerConnect News:  According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib).1 About... Continue Reading

TheraSphere® Shows Promise in Treatment of Liver Metastases (03-31-2009)

Among patients with colorectal cancer that has spread to the liver, treatment of the liver with TheraSphere® (yttrium-90 glass microspheres) appears to provide sustained stabilization of disease. These results were published in the journal Cancer. Colorectal... Continue Reading

Treatment of Hepatocellular Carcinoma (03-18-2009)

Overview The following is a general overview of the treatment of hepatocellular carcinoma, the most common type of primary liver cancer. Choice of treatment will depend on the extent and location of the cancer, the health of the liver, and the overall... Continue Reading

Liver Cancer Screening/Prevention (03-18-2009)

Overview Information about the prevention of cancer and the science of screening appropriate individuals at high risk of developing cancer is gaining interest. Physicians and individuals alike recognize that the best ”treatment“ of cancer is preventing... Continue Reading

Liver Cancer Overview (03-18-2009)

Overview The liver is the largest organ inside of the body. It is located on the right side of the abdomen behind the ribs. The liver has many important functions, including:[1]  Removing harmful substances from the blood. Making bile that helps in... Continue Reading

Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% (10-30-2008)

Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% The risk of the spread of cancer along the path of the needle (needle track seeding) during a biopsy for hepatocellular carcinoma... Continue Reading

Genes Outside of Cancer Help Predict Outcomes of Liver Cancer Patients (10-21-2008)

Genes Outside of Cancer Help Predict Outcomes of Liver Cancer Patients Genes that can be measured directly adjacent to the site of a liver cancer can help predict survival among patients diagnosed with the most common type of liver cancer, hepatocellular... Continue Reading